BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Diagnosis
202 results:

  • 1. [Gene Profile and Clinical Significance of Concomitant Mutations in CN-AML Patients with
    Zhu J; Kang YF; Gao Y; Wang HW; Hao ZH; Wang HW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):335-341. PubMed ID: 38660833
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical significance of monitoring NUP98::NSD1 fusion genes before and after allogeneic hematopoietic stem cell transplantation].
    Shang YK; Pan XA; Chang YJ; Qin YQ; Wang Y; Yan CH; Sun YQ; Huang XJ; Zhao XS
    Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):1010-1015. PubMed ID: 38503524
    [No Abstract]    [Full Text] [Related]  

  • 3. wt1 and TP53 as valuable diagnostic biomarkers for relapse after hematopoietic stem cell transplantation in acute myeloid leukemia.
    Asghari-Ghomi A; Fallahian F; Garavand J; Mohammadi MH
    Mol Biol Rep; 2024 Feb; 51(1):244. PubMed ID: 38300383
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Choi YJ; Min YK; Lee ST; Choi JR; Shin S
    Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical significance of wt1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia.
    Yu T; Zhan Q; Yan X; Luo X; Wang X; Tang X; Zhang H; Yang Z; Chen J; Liu L; Wang L
    Cancer Biol Ther; 2023 Dec; 24(1):2285801. PubMed ID: 38031921
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic Mutation Profiles of Patients with Acute Myeloid leukemia in Korea: a Single-Center Experience.
    Han E; Ryu S; Kim D; Koh EH; Byun JH; Lee DH
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948498
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [leukemia Genotype Analysis of Children with Acute Lymphoblastic leukemia in Yunnan Area].
    Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.
    Miyajima T; Onozawa M; Yoshida S; Miyashita N; Kimura H; Takahashi S; Yokoyama S; Matsukawa T; Goto H; Sugita J; Fujisawa S; Hidaka D; Ogasawara R; Mori A; Matsuoka S; Shigematsu A; Wakasa K; Kasahara I; Saga T; Hashiguchi J; Takeda Y; Ibata M; Yutaka T; Fujimoto K; Kondo T; Teshima T
    Eur J Haematol; 2023 Oct; 111(4):620-627. PubMed ID: 37465857
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic value of combined wt1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia.
    Ding Y; Liu Z; Wang H; Xiong S; Zhai Z
    Scand J Clin Lab Invest; 2023 Sep; 83(5):340-347. PubMed ID: 37355341
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid leukemia.
    Krizsán S; Péterffy B; Egyed B; Nagy T; Sebestyén E; Hegyi LL; Jakab Z; Erdélyi DJ; Müller J; Péter G; Csanádi K; Kállay K; Kriván G; Barna G; Bedics G; Haltrich I; Ottóffy G; Csernus K; Vojcek Á; Tiszlavicz LG; Gábor KM; Kelemen Á; Hauser P; Gaál Z; Szegedi I; Ujfalusi A; Kajtár B; Kiss C; Matolcsy A; Tímár B; Kovács G; Alpár D; Bödör C
    J Mol Diagn; 2023 Aug; 25(8):555-568. PubMed ID: 37088137
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia.
    Duployez N; Vasseur L; Kim R; Largeaud L; Passet M; L'Haridon A; Lemaire P; Fenwarth L; Geffroy S; Helevaut N; Celli-Lebras K; Adès L; Lebon D; Berthon C; Marceau-Renaut A; Cheok M; Lambert J; Récher C; Raffoux E; Micol JB; Pigneux A; Gardin C; Delabesse E; Soulier J; Hunault M; Dombret H; Itzykson R; Clappier E; Preudhomme C
    Leukemia; 2023 Jun; 37(6):1245-1253. PubMed ID: 37085611
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A global study for acute myeloid leukemia with RARG rearrangement.
    Zhu HH; Qin YZ; Zhang ZL; Liu YJ; Wen LJ; You MJ; Zhang C; Such E; Luo H; Yuan HJ; Zhou HS; Liu HX; Xu R; Li J; Li JH; Hao JP; Jin J; Yu L; Zhang JY; Liu LP; Zhang LP; Huang RB; Shen SH; Gao SJ; Wang W; Yan XJ; Zhang XY; Du X; Chu XX; Yu YF; Wang Y; Mi YC; Lu Y; Cai Z; Su Z; Taussig DC; MacMahon S; Ball ED; Wang HY; Welch JS; Yin CC; Borthakur G; Sanz MA; Kantarjian HM; Huang JY; Hu J; Chen SN
    Blood Adv; 2023 Jul; 7(13):2972-2982. PubMed ID: 36799929
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High wt1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk.
    Xu N; Chen WM; Li LD; Long LY; Wang X; Jiang Q; Jiang H; Huang XJ; Qin YZ
    Clin Exp Med; 2023 Oct; 23(6):2629-2638. PubMed ID: 36637581
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Study of mRNA of wt1, BAALC, EVI1, PRAME and HMGA2 genes in whole blood samples.
    Olkhovskiy IA; Gorbenko AS; Stolyar MA; Bakhtina VI; Mikhalev MA; Olkhovik TI; Sudarikov AB; Sidorova YS; Pospelova TI; Kolesnikova MA; Kaporskaya TS; Lyskova VA
    Klin Lab Diagn; 2022 Oct; 67(10):613-620. PubMed ID: 36315178
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic Landscape of Mixed-Phenotype Acute leukemia.
    Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Immunophenotypic Features and Clinical Prognosis of Patients with Mixed Phenotype Acute leukemia].
    Liu TQ; Huang S; Li XY; Li BX; Yao B; Zhang R; Wang Y; Liu ZQ; Hu KX; Cai B; Yu CL; Qiao JH; Guo M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1305-1310. PubMed ID: 36208227
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Transformation from polycythemia vera to acute promyelocytic leukemia: Case report and literature review.
    Li WW; Sui XF; Fan S; Xu H; Wang CL; Wang FY; Mo XD
    Medicine (Baltimore); 2022 Aug; 101(32):e30064. PubMed ID: 35960050
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Development and validation of a prognostic scoring model to risk stratify childhood acute myeloid leukaemia.
    Li J; Liu L; Zhang R; Wan Y; Gong X; Zhang L; Yang W; Chen X; Zou Y; Chen Y; Guo Y; Ruan M; Zhu X
    Br J Haematol; 2022 Sep; 198(6):1041-1050. PubMed ID: 35880261
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity.
    Mopin A; Leprêtre F; Sebda S; Villenet C; Ben Khoud M; Figeac M; Quesnel B; Brinster C
    PLoS One; 2022; 17(4):e0267508. PubMed ID: 35486629
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Platelet to white blood cell ratio was an independent prognostic predictor in acute myeloid leukemia.
    Zhao S; Pan H; Guo Q; Xie W; Wang J
    Hematology; 2022 Dec; 27(1):426-430. PubMed ID: 35413229
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.